METROGYL

This brand name is authorized in Australia, Hong Kong SAR China, New Zealand, Tunisia.

Active ingredients

The drug METROGYL contains one active pharmaceutical ingredient (API):

1	Methronidazole UNII 140QMO216E - METRONIDAZOLE
	Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.
	Read more about Methronidazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XD01	Metronidazole	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives
Discover more medicines within J01XD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1621H, 1636D, 3339R, 5155H
HK	Department of Health Drug Office	33005, 33939
NZ	Medicines and Medical Devices Safety Authority	20188, 20212
TN	Direction de la Pharmacie et du Médicament	9003771, 9003772H, 9003773H